Home › Forums › Infexion Connexion › re Candida Auris
- This topic has 0 replies, 4 voices, and was last updated 5 years, 9 months ago by
Donna Cameron.
-
AuthorPosts
-
06/11/2018 at 1:21 pm #74916
Dear All, just updating our MRO policy with reference to C.auris – which sites are we meant to screen ? I$B!G(Bve read a lot of literature but there is nothing specifically outling the testing sites.
I$B!G(Bm thinking;
Groin/ perineum &
Additional specimens should be obtained as follows: (if relevant)
$B!|(B Urine – voided or catheter urine
$B!|(B Skin lesions and wound swabs
$B!|(B Swabs of sites of catheters or other skin penetrating devicesAprreciate your advice
Emma Trippe
Infection Control Consultant
[cid:image001.png@01D475D3.A2307160]
Calvary Riverina Hospital
Hardy Avenue Wagga Wagga NSW 2650
P: 02 6932 1628
E: Emma.Trippe@calvarycare.org.au
http://www.calvary-wagga.com.auHospitality | Healing | Stewardship | Respect
Continuing the Mission of the Sisters of the Little Company of MaryThis email is confidential and may be subject to copyright and legal professional privilege. If this email is not intended for you please do not use the information in any way, but delete and notify us immediately. For full copy of our Privacy Policy please visit
http://www.calvarycare.org.au.MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.
The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.
Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au
To send a message to the list administrator send an email to admin@acipc.org.au
You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.au
06/11/2018 at 2:27 pm #74917Just wondering what cohort of people would you screen?
I have had a look on CDC and there seems to be only advice for those who have tested positive and their contacts.
Cheers,
Sharon Deen
Infection Control Nurse[http://www.ramsayhealth.com/~/media/Images/email/email-RHC-logo.jpg]
Peel Health Campus
Infection Control
Phone:08 9531 8570
Fax:
08 9531 8409
Email:
DeenSharon@ramsayhealth.com.au
Web:
Address:
110 Lakes Road, Mandurah WA 6210
[http://www.ramsayhealth.com/~/media/Images/email/email-social-media2.jpg]
Dear All, just updating our MRO policy with reference to C.auris – which sites are we meant to screen ? I$B!G(Bve read a lot of literature but there is nothing specifically outling the testing sites.
I$B!G(Bm thinking;
Groin/ perineum &
Additional specimens should be obtained as follows: (if relevant)
$B!|(B Urine – voided or catheter urine
$B!|(B Skin lesions and wound swabs
$B!|(B Swabs of sites of catheters or other skin penetrating devicesAprreciate your advice
Emma Trippe
Infection Control Consultant
[cid:image001.png@01D475D3.A2307160]
Calvary Riverina Hospital
Hardy Avenue Wagga Wagga NSW 2650
P: 02 6932 1628
E: Emma.Trippe@calvarycare.org.au
http://www.calvary-wagga.com.auHospitality | Healing | Stewardship | Respect
Continuing the Mission of the Sisters of the Little Company of MaryThis email is confidential and may be subject to copyright and legal professional privilege. If this email is not intended for you please do not use the information in any way, but delete and notify us immediately. For full copy of our Privacy Policy please visit
http://www.calvarycare.org.au.
MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.
Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au
To send a message to the list administrator send an email to admin@acipc.org.au
You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.au
This e-mail message and any accompanying files may contain
information that is confidential and subject to privilege. If you
are not the intended recipient, and have received the e-mail
in error, you are notified that any use, dissemination,
distribution, forwarding, printing or copying of the message
and any attached files is strictly prohibited. If you have
received this e-mail message in error please immediately
advise the sender by return e-mail, or telephone 1800 243 903.
You must destroy the original transmission and its contents.
Any views expressed within this communication are those of
the individual sender, except where the sender specifically
states them to be the views of Ramsay Health Care.
This communication should not be copied or disseminated
without permission.MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.
The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.
Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au
To send a message to the list administrator send an email to admin@acipc.org.au
You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.au
06/11/2018 at 2:49 pm #74918Hi Sharon
I think she means contact screening. This is what the Commonwealth document says:
4.9. Screening Close contacts or roommates of the colonised or infected patient who were in the same bay/room for longer than 24 hours with an affected patient in the 28 days prior to first identification should be screened for C. auris colonisation. Newly identified colonised patients should be isolated and managed as in 4.4 Managing transmission above. The aim is to prevent the spread of C. auris to those most at risk of becoming infected. If contacts have already been discharged then the facility should provide consumer information to the patient and, where able, contact the patient$B!G(Bs general practitioner. All healthcare facilities should have a system for identifying patients at re-admission or outpatient attendance who have previously isolated the organism or who are identified as a contact but have not been cleared of colonisation. Similarly, patients who have been inpatients of a hospital in another country which has reported multiple cases and/or transmission should be identified at presentation and screened. Screening samples should be collected on three consecutive days. Screening should be undertaken promptly. Screening performed whilst the patient is on antifungal medication or had been treated within the preceding 7 days or who had been exposed to topical antiseptic washes in the preceding 48 hours must be repeated when such factors no longer apply before a negative result can be considered valid. Screening should consist of taking swabs from both axilla and both sides of the groin which can be pooled and processed as the one sample by the laboratory. If screening a patient who is known to be previously colonised or infected with C. auris, it is recommended that the original site of colonisation as well as axilla/groins are sampled. The laboratory must be informed that C. auris is under investigation.
From https://www.health.qld.gov.au/__data/assets/pdf_file/0028/722827/Candida-auris-guideline.pdf
Cheers
MichaelMichael Wishart, CICP-E
Infection Control CoordinatorA 627 Rode Road, Chermside QLD 4032
P (07) 3326 3068 | F (07) 3607 2226 | E michael.wishart@svha.org.au | W http://www.hsnph.org.au
[cid:image001.png@01D01926.61F1C2B0] [cid:image002.png@01D475D7.7EDD5580]
P Please consider the environment before printing this emailJust wondering what cohort of people would you screen?
I have had a look on CDC and there seems to be only advice for those who have tested positive and their contacts.
Cheers,
Sharon Deen
Infection Control Nurse[http://www.ramsayhealth.com/~/media/Images/email/email-RHC-logo.jpg]
Peel Health Campus
Infection Control
Phone:08 9531 8570
Fax:
08 9531 8409
Email:
DeenSharon@ramsayhealth.com.au
Web:
Address:
110 Lakes Road, Mandurah WA 6210
[http://www.ramsayhealth.com/~/media/Images/email/email-social-media2.jpg]
Dear All, just updating our MRO policy with reference to C.auris – which sites are we meant to screen ? I$B!G(Bve read a lot of literature but there is nothing specifically outling the testing sites.
I$B!G(Bm thinking;
Groin/ perineum &
Additional specimens should be obtained as follows: (if relevant)
$B!|(B Urine – voided or catheter urine
$B!|(B Skin lesions and wound swabs
$B!|(B Swabs of sites of catheters or other skin penetrating devicesAprreciate your advice
Emma Trippe
Infection Control Consultant
[cid:image001.png@01D475D3.A2307160]
Calvary Riverina Hospital
Hardy Avenue Wagga Wagga NSW 2650
P: 02 6932 1628
E: Emma.Trippe@calvarycare.org.au
http://www.calvary-wagga.com.auHospitality | Healing | Stewardship | Respect
Continuing the Mission of the Sisters of the Little Company of MaryThis email is confidential and may be subject to copyright and legal professional privilege. If this email is not intended for you please do not use the information in any way, but delete and notify us immediately. For full copy of our Privacy Policy please visit
http://www.calvarycare.org.au.
MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.
Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au
To send a message to the list administrator send an email to admin@acipc.org.au
You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.au
This e-mail message and any accompanying files may contain
information that is confidential and subject to privilege. If you
are not the intended recipient, and have received the e-mail
in error, you are notified that any use, dissemination,
distribution, forwarding, printing or copying of the message
and any attached files is strictly prohibited. If you have
received this e-mail message in error please immediately
advise the sender by return e-mail, or telephone 1800 243 903.
You must destroy the original transmission and its contents.
Any views expressed within this communication are those of
the individual sender, except where the sender specifically
states them to be the views of Ramsay Health Care.
This communication should not be copied or disseminated
without permission.______________________________________________________________________
This email and any attachments to it (the “Email”) is confidential and is for the use only of the intended recipient, and may not be duplicated or used by any other party without the express consent of the sender. If you are not the intended recipient of the Email, please notify the sender immediately by return https://clicktime.symantec.com/a/1/X26NYJ2B8fH7L6Jzy34AQ1eG6ob6CiqfIMfVyCLIV98?distLOAfHrPPW1ykfhUpVSMgFNeLxRfYZdlk8mxpGF7YuVh0_SWmkwhVOTOvXnZi4B3JnwSmHQzAzonrfWC-ugXPL-9KnIieYbXeRRy6nn24wS5oQIc-Q4WHDIJXcRUv_4IDuiA8xAI7mipze95O69Uvh2SzrkdzKPxY0dR7yOeZ5wgdSzrSPuwGVvNbmGZmrMVeo8qca5FidH0TlIgUjWjg18mDOB0JxyHLU24-rgyvEzfR8WBkNojlGAxGZFsIRe-I3ij6WrrlMHT2Z31c7cTmacD_G7UMVpIiRJLXNnhU7yuGNyIpaq0TWxCLU2AQ1lYH2BAnSFrxZGC2k530-PlZngEN43cpmeq5N-v-aXsdilDrG2QPRtWDEDjThOgu74LDbQPFBWdpmFcNqod8DAASFUw%3D%3D&uemail%2C%20delete%20the%20Email%2C%20and%20do not copy, print, retransmit, store or act in reliance on the Email. St Vincent’s Health Australia (“SVHA”) does not guarantee that the Email is free from errors, viruses or interference. Emails to and from SVHA or its related entities may be scanned and filtered in locations outside Australia.
MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.
Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au
To send a message to the list administrator send an email to admin@acipc.org.au
You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.au
______________________________________________________________________
This email and any attachments to it (the “Email”) is confidential and is for the use only of the intended recipient, and may not be duplicated or used by any other party without the express consent of the sender. If you are not the intended recipient of the Email, please notify the sender immediately by return email, delete the Email, and do not copy, print, retransmit, store or act in reliance on the Email. St Vincent’s Health Australia (“SVHA”) does not guarantee that the Email is free from errors, viruses or interference. Emails to and from SVHA or its related entities may be scanned and filtered in locations outside Australia.MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.
The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.
Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au
To send a message to the list administrator send an email to admin@acipc.org.au
You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.au
07/11/2018 at 9:12 am #74920Donna Cameron
ParticipantAuthor:
Donna CameronPosition:
Infection Control ConsultantOrganisation:
University of MelbourneState:
VICHi Emma,
CDC, Public Health England & the European CDC all recommend groin and axilla swabs for screening. Other sites such as urine, wounds indwelling device sites etc can be included but the minimum should be groin and axilla.
Groin and axilla swabs is what was recommended for screening contacts of the recent Victorian cases. We also included:
* Wounds
* Exit sites of indwelling devices (e.g. PEGs)
* Urine if they had an IDC
* Sputum if they had a trache
Reference to groin and axilla swabs (and other recommended sites) can be found here:
CDC, Recommendations for Infection Prevention and Control for Candida auris (look under $B!H(BHow to screen$B!I(B heading) https://www.cdc.gov/fungal/candida-auris/c-auris-infection-control.html
PHE, Guidance for the laboratory investigation management and infection prevention and control for cases of C. auris (see $B!H(BScreening policies$B!I(B on page 8) https://www.gov.uk/government/collections/candida-auris#guidance-for-laboratories,-healthcare-providers-and-healthcare-professionals
European CDC, Candida auris in healthcare settings – Europe (see $B!H(BPreventing transmission from patients known to carry C. auris$B!I(B) https://ecdc.europa.eu/en/publications-data/rapid-risk-assessment-candida-auris-healthcare-settings-europeRegards,
DonnaDonna Cameron
Infection Control Consultant
T +61 (0) 3 8344 3574 (Monday, Wednesday & Friday); +61 (0) 3 9096 5233 (Tuesday & Thursday)
donna.cameron@unimelb.edu.au
Microbiological Diagnostic Unit Public Health Laboratory
The Peter Doherty Institute for Infection and Immunity
792 Elizabeth Street | Melbourne | Victoria | Australia | 3000
doherty.edu.auDear All, just updating our MRO policy with reference to C.auris – which sites are we meant to screen ? I$B!G(Bve read a lot of literature but there is nothing specifically outling the testing sites.
I$B!G(Bm thinking;
Groin/ perineum &
Additional specimens should be obtained as follows: (if relevant)
$B!|(B Urine – voided or catheter urine
$B!|(B Skin lesions and wound swabs
$B!|(B Swabs of sites of catheters or other skin penetrating devicesAprreciate your advice
Emma Trippe
Infection Control Consultant
[cid:image001.png@01D475D3.A2307160]
Calvary Riverina Hospital
Hardy Avenue Wagga Wagga NSW 2650
P: 02 6932 1628
E: Emma.Trippe@calvarycare.org.au
http://www.calvary-wagga.com.auHospitality | Healing | Stewardship | Respect
Continuing the Mission of the Sisters of the Little Company of MaryThis email is confidential and may be subject to copyright and legal professional privilege. If this email is not intended for you please do not use the information in any way, but delete and notify us immediately. For full copy of our Privacy Policy please visit
http://www.calvarycare.org.au.
MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.
Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au
To send a message to the list administrator send an email to admin@acipc.org.au
You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.au
MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.
The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.
Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au
To send a message to the list administrator send an email to admin@acipc.org.au
You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.au
07/11/2018 at 9:18 am #74921Donna Cameron
ParticipantAuthor:
Donna CameronPosition:
Infection Control ConsultantOrganisation:
University of MelbourneState:
VICHi Sharon,
Apart from known C. auris contacts, you may want to consider screening any patients who have been admitted to an overseas health care facility in the previous 12 months, the same as you should be screening them for CPE and other MROs. My understanding is that all cases to date in Australia have had a history of admission to an overseas hospital.
Regards,
DonnaDonna Cameron
Infection Control Consultant
T +61 (0) 3 8344 3574 (Monday, Wednesday & Friday); +61 (0) 3 9096 5233 (Tuesday & Thursday)
donna.cameron@unimelb.edu.au
Microbiological Diagnostic Unit Public Health Laboratory
The Peter Doherty Institute for Infection and Immunity
792 Elizabeth Street | Melbourne | Victoria | Australia | 3000
doherty.edu.auJust wondering what cohort of people would you screen?
I have had a look on CDC and there seems to be only advice for those who have tested positive and their contacts.
Cheers,
Sharon Deen
Infection Control Nurse[http://www.ramsayhealth.com/~/media/Images/email/email-RHC-logo.jpg]
Peel Health Campus
Infection Control
Phone:08 9531 8570
Fax:
08 9531 8409
Email:
DeenSharon@ramsayhealth.com.au
Web:
Address:
110 Lakes Road, Mandurah WA 6210
[http://www.ramsayhealth.com/~/media/Images/email/email-social-media2.jpg]
Dear All, just updating our MRO policy with reference to C.auris – which sites are we meant to screen ? I$B!G(Bve read a lot of literature but there is nothing specifically outling the testing sites.
I$B!G(Bm thinking;
Groin/ perineum &
Additional specimens should be obtained as follows: (if relevant)
$B!|(B Urine – voided or catheter urine
$B!|(B Skin lesions and wound swabs
$B!|(B Swabs of sites of catheters or other skin penetrating devicesAprreciate your advice
Emma Trippe
Infection Control Consultant
[cid:image001.png@01D475D3.A2307160]
Calvary Riverina Hospital
Hardy Avenue Wagga Wagga NSW 2650
P: 02 6932 1628
E: Emma.Trippe@calvarycare.org.au
http://www.calvary-wagga.com.auHospitality | Healing | Stewardship | Respect
Continuing the Mission of the Sisters of the Little Company of MaryThis email is confidential and may be subject to copyright and legal professional privilege. If this email is not intended for you please do not use the information in any way, but delete and notify us immediately. For full copy of our Privacy Policy please visit
http://www.calvarycare.org.au.
MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.
Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au
To send a message to the list administrator send an email to admin@acipc.org.au
You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.au
This e-mail message and any accompanying files may contain
information that is confidential and subject to privilege. If you
are not the intended recipient, and have received the e-mail
in error, you are notified that any use, dissemination,
distribution, forwarding, printing or copying of the message
and any attached files is strictly prohibited. If you have
received this e-mail message in error please immediately
advise the sender by return e-mail, or telephone 1800 243 903.
You must destroy the original transmission and its contents.
Any views expressed within this communication are those of
the individual sender, except where the sender specifically
states them to be the views of Ramsay Health Care.
This communication should not be copied or disseminated
without permission.
MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.
Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au
To send a message to the list administrator send an email to admin@acipc.org.au
You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.au
MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.
The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.
Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.
Replies to this message will be directed back to the list. To create a new message send an email to acipclist@acipc.org.au
To send a message to the list administrator send an email to admin@acipc.org.au
You can unsubscribe manually from this list by sending ‘signoff acipclist’ (without the quotes) to listserv@aicalist.org.au
-
AuthorPosts
- The forum ‘Infexion Connexion’ is closed to new topics and replies.